+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Blood Cancer Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026

  • ID: 5235868
  • Report
  • December 2020
  • Region: Global
  • 100 pages
  • Infinium Global Research

FEATURED COMPANIES

  • Amgen Inc
  • Astellas Pharma Inc
  • AstraZeneca PLC
  • Bayer AG
  • Celgene Corporation
  • Eli Lilly
The report on the global blood cancer drugs market provides qualitative and quantitative analysis for the period from 2018 to 2026. The report predicts the global blood cancer drugs market to grow with a CAGR of 11.5% over the forecast period from 2020-2026. The study on blood cancer drugs market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2018 to 2026.

The report on blood cancer drugs market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global blood cancer drugs market over the period of 2018 to 2026. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global blood cancer drugs market over the period of 2018 to 2026. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Research Methodology

A) Primary Research
The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global blood cancer drugs market is segmented on the basis of product, treatment approach, and application.

The Global Blood Cancer Drugs Market by Product
  • Rituaxan/Mabthera
  • Gleevac/Glivec
  • Revlimid
  • Velcade
  • Tasigna
  • Pomalyst
  • Vidaza
  • Others
The Global Blood Cancer Drugs Market by Treatment Approach
  • Chemotherapeutic
  • Targeted Therapies
  • Immunotherapeutic
The Global Blood Cancer Drugs Market by Application
  • Leukemia
  • Lymphoma
  • Multiple Myeloma
Company Profiles
The companies covered in the report include
  • Amgen Inc
  • AstraZeneca PLC
  • Astellas Pharma Inc
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Eli Lilly
  • F.Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Novartis
What does this Report Deliver?
1. Comprehensive analysis of the global as well as regional markets of the blood cancer drugs market.
2. Complete coverage of all the segments in the blood cancer drugs market to analyze the trends, developments in the global market and forecast of market size up to 2026.
3. Comprehensive analysis of the companies operating in the global blood cancer drugs market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amgen Inc
  • Astellas Pharma Inc
  • AstraZeneca PLC
  • Bayer AG
  • Celgene Corporation
  • Eli Lilly
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Blood Cancer Drugs Market Highlights
2.2. Blood Cancer Drugs Market Projection
2.3. Blood Cancer Drugs Market Regional Highlights

3. Global Blood Cancer Drugs Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Analysis of COVID-19 impact on the Blood Cancer Drugs Market
3.4. Porter's Five Forces Analysis
3.5. Growth Matrix Analysis
3.5.1. Growth Matrix Analysis by Product
3.5.2. Growth Matrix Analysis by Treatment Approach
3.5.3. Growth Matrix Analysis by Application
3.5.4. Growth Matrix Analysis by Region
3.6. Value Chain Analysis of Blood Cancer Drugs Market

4. Blood Cancer Drugs Market Macro Indicator Analysis

5. Global Blood Cancer Drugs Market by Product
5.1. Rituaxan/Mabthera
5.2. Gleevac/Glivec
5.3. Revlimid
5.4. Velcade
5.5. Tasigna
5.6. Pomalyst
5.7. Vidaza
5.8. Others

6. Global Blood Cancer Drugs Market by Treatment Approach
6.1. Chemotherapeutic
6.2. Targeted Therapies
6.3. Immunotherapeutic

7. Global Blood Cancer Drugs Market by Application
7.1. Leukemia
7.2. Lymphoma
7.3. Multiple Myeloma

8. Global Blood Cancer Drugs Market by Region 2020-2026
8.1. North America
8.1.1. North America Blood Cancer Drugs Market by Product
8.1.2. North America Blood Cancer Drugs Market by Treatment Approach
8.1.3. North America Blood Cancer Drugs Market by Application
8.1.4. North America Blood Cancer Drugs Market by Country
8.2. Europe
8.2.1. Europe Blood Cancer Drugs Market by Product
8.2.2. Europe Blood Cancer Drugs Market by Treatment Approach
8.2.3. Europe Blood Cancer Drugs Market by Application
8.2.4. Europe Blood Cancer Drugs Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific Blood Cancer Drugs Market by Product
8.3.2. Asia-Pacific Blood Cancer Drugs Market by Treatment Approach
8.3.3. Asia-Pacific Blood Cancer Drugs Market by Application
8.3.4. Asia-Pacific Blood Cancer Drugs Market by Country
8.4. RoW
8.4.1. RoW Blood Cancer Drugs Market by Product
8.4.2. RoW Blood Cancer Drugs Market by Treatment Approach
8.4.3. RoW Blood Cancer Drugs Market by Application
8.4.4. RoW Blood Cancer Drugs Market by Sub-region

9. Company Profiles and Competitive Landscape
9.1. Competitive Landscape in the Global Blood Cancer Drugs Market
9.2. Companies Profiled
9.2.1. Amgen Inc
9.2.2. AstraZeneca PLC
9.2.3. Astellas Pharma Inc
9.2.4. Bayer AG
9.2.5. Bristol-Myers Squibb Company
9.2.6. Celgene Corporation
9.2.7. Eli Lilly
9.2.8. F.Hoffmann-La Roche Ltd
9.2.9. Johnson & Johnson
9.2.10. Novartis
Note: Product cover images may vary from those shown
  • Amgen Inc
  • AstraZeneca PLC
  • Astellas Pharma Inc
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Eli Lilly
  • F.Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Novartis
Note: Product cover images may vary from those shown
Adroll
adroll